Leukemia and lymphomas are some of the most common cancers that affect children, adolescents and young adults. They are highly diverse and require an individualized approach to diagnosis and therapy. In collaboration with the Vanderbilt-Ingram Cancer Center, we offer access to new and leading-edge treatment and clinical trials. Our team of experts will follow your child throughout their cancer journey.
As part of the Vanderbilt-Ingram Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute, we have internationally recognized leaders in leukemia and lymphoma clinical care and research.
With our unique team approach, we have expertise treating children, adolescents and young adults with many clinical trial options.
In addition to chemotherapy, we are able to offer a new and exciting therapy for hard to treat or recurrent leukemia. CAR T cell therapy takes your child’s own immune cells and reprograms them to kill the leukemia. Together with the Vanderbilt-Ingram Cancer Center, we are only one of a small number of institutions in the country in the nation to offer CAR T cell therapy for recurrent leukemia and lymphoma in children, adolescents and young adults, as well as chemotherapy, immunotherapy and stem cell transplant.
A team of pediatric oncologists, surgeons, radiation oncologists, other medical specialists, geneticists, nurses, social workers, psychologists, physical therapists, teachers and nutritionists work together to provide fully coordinated medical and supportive care.